342 related articles for article (PubMed ID: 21666428)
1. Quality of life in patients with irritable bowel syndrome.
Mönnikes H
J Clin Gastroenterol; 2011 Aug; 45 Suppl():S98-101. PubMed ID: 21666428
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
Rahimi R; Nikfar S; Abdollahi M
Clin Ther; 2008 May; 30(5):884-901. PubMed ID: 18555935
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study.
Paré P; Gray J; Lam S; Balshaw R; Khorasheh S; Barbeau M; Kelly S; McBurney CR
Clin Ther; 2006 Oct; 28(10):1726-35; discussion 1710-1. PubMed ID: 17157129
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
5. Impact of upper digestive symptoms in patients with irritable bowel syndrome.
Balboa A; Mearin F; Badía X; Benavent J; Caballero AM; Domínguez-Muñoz JE; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
Eur J Gastroenterol Hepatol; 2006 Dec; 18(12):1271-7. PubMed ID: 17099375
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, characteristics, and impact of bloating symptoms in patients with irritable bowel syndrome.
Ringel Y; Williams RE; Kalilani L; Cook SF
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):68-72; quiz 3. PubMed ID: 19124113
[TBL] [Abstract][Full Text] [Related]
7. Functional bowel disorders in primary care: factors associated with health-related quality of life and doctor consultation.
Lee V; Guthrie E; Robinson A; Kennedy A; Tomenson B; Rogers A; Thompson D
J Psychosom Res; 2008 Feb; 64(2):129-38. PubMed ID: 18222126
[TBL] [Abstract][Full Text] [Related]
8. Clinical determinants of health-related quality of life in patients with irritable bowel syndrome.
Spiegel BM; Gralnek IM; Bolus R; Chang L; Dulai GS; Mayer EA; Naliboff B
Arch Intern Med; 2004 Sep; 164(16):1773-80. PubMed ID: 15364671
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, bowel habit subtypes and medical care-seeking behaviour of patients with irritable bowel syndrome in Northern Greece.
Katsinelos P; Lazaraki G; Kountouras J; Paroutoglou G; Oikonomidou I; Mimidis K; Koutras C; Gelas G; Tziomalos K; Zavos C; Pilpilidis I; Chatzimavroudis G
Eur J Gastroenterol Hepatol; 2009 Feb; 21(2):183-9. PubMed ID: 19212207
[TBL] [Abstract][Full Text] [Related]
10. Item-level assessment of the irritable bowel syndrome quality of life questionnaire in patients with diarrheal irritable bowel syndrome.
Andrae DA; Covington PS; Patrick DL
Clin Ther; 2014 May; 36(5):663-79. PubMed ID: 24813429
[TBL] [Abstract][Full Text] [Related]
11. Characterization of the alternating bowel habit subtype in patients with irritable bowel syndrome.
Tillisch K; Labus JS; Naliboff BD; Bolus R; Shetzline M; Mayer EA; Chang L
Am J Gastroenterol; 2005 Apr; 100(4):896-904. PubMed ID: 15784038
[TBL] [Abstract][Full Text] [Related]
12. The impact of treatment with eluxadoline on health-related quality of life among adult patients with irritable bowel syndrome with diarrhea.
Abel JL; Carson RT; Andrae DA
Qual Life Res; 2019 Feb; 28(2):369-377. PubMed ID: 30267294
[TBL] [Abstract][Full Text] [Related]
13. Concomitant functional dyspepsia and irritable bowel syndrome decrease health-related quality of life in gastroesophageal reflux disease.
De Vries DR; Van Herwaarden MA; Baron A; Smout AJ; Samsom M
Scand J Gastroenterol; 2007 Aug; 42(8):951-6. PubMed ID: 17613924
[TBL] [Abstract][Full Text] [Related]
14. Irritable bowel syndrome: a mild disorder; purely symptomatic treatment.
Prescrire Int; 2009 Apr; 18(100):75-9. PubMed ID: 19585728
[TBL] [Abstract][Full Text] [Related]
15. The spectrum of irritable bowel syndrome: A clinical review.
Gilkin RJ
Clin Ther; 2005 Nov; 27(11):1696-709. PubMed ID: 16368443
[TBL] [Abstract][Full Text] [Related]
16. A population-based case-control study of work and psychosocial problems in patients with irritable bowel syndrome--women are more seriously affected than men.
Faresjö A; Grodzinsky E; Johansson S; Wallander MA; Timpka T; Akerlind I
Am J Gastroenterol; 2007 Feb; 102(2):371-9. PubMed ID: 17156145
[TBL] [Abstract][Full Text] [Related]
17. Quality of life measures in irritable bowel syndrome.
Wong RK; Drossman DA
Expert Rev Gastroenterol Hepatol; 2010 Jun; 4(3):277-84. PubMed ID: 20528115
[TBL] [Abstract][Full Text] [Related]
18. Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes.
Bleser S
Curr Med Res Opin; 2011 Mar; 27(3):503-12. PubMed ID: 21208139
[TBL] [Abstract][Full Text] [Related]
19. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
20. Quality of life in patients with inflammatory bowel disease and irritable bowel syndrome differs between subjects recruited from clinic or the internet.
Jones MP; Bratten J; Keefer L
Am J Gastroenterol; 2007 Oct; 102(10):2232-7. PubMed ID: 17680842
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
